Additionally, the tumor microenvironment of 50% of HNSCC patients demonstrates an overexpression of HGF which has been reported to increase resistance to radiotherapy and to MET targeting tyrosine kinase inhibitor JNJ-38877605 via the association of PI3K-GAB1 [6, 41]. The gene discussed is MET; the disease is neoplasm.